Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

I reiterate a 'Strong Buy' rating for Alcon with a one-year price target of $115 per share, driven by new product pipelines and FDA clearances. Alcon's Unity VCS/CS systems received FDA clearance, set ...

I reiterate a 'Strong Buy' rating for Alcon with a one-year price target of $118 per share, despite a minor guidance cut. Alcon's new product launches, including PRECISION7 and Systane Pro, are ...

Alcon’s ALC business is dented by a challenging international market with subdued demand for ophthalmological products. Also, a tough competitive landscape is a threat. The stock carries a Zacks Rank ...

Alcon (SWX:ALC) has quietly clawed back some ground over the past month, even though its shares are still down sharply for the year. That gap between recent momentum and longer term underperformance ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Alcon Plc’s (NYSE:ALC) Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for signs and symptoms of Dry Eye ...

Alcon has a vision for its future, and Fort Worth is a focal point of it. The company that specializes in eye care and surgical products and was founded in Fort Worth in 1945, will be spun off from ...

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract System ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager ™ DSLT, the ...

In the Adhishthana framework, Phases 4 through 8 typically form the Cakra, a bullish arc structure that consolidates momentum before breaking out in Phase 9. That breakout normally signals the start ...

GENEVA & DURHAM, N.C.--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”), a ...